Optimization of patient selection for neoadjuvant chemotherapy in muscle-invasive urothelial carcinoma of the bladder

PJ Hensley, J Goodwin, DL Davenport, SE Strup… - Clinical genitourinary …, 2018 - Elsevier
Background Radical cystectomy (RC) is delayed in a subset of patients who respond poorly
to neoadjuvant chemotherapy (NAC). The present study investigated the clinicopathologic …

Effectiveness of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the current real world setting in the USA

N Hanna, QD Trinh, T Seisen, MW Vetterlein… - European urology …, 2018 - Elsevier
Background The use of neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) is
supported by results from several randomized control trials, including SWOG-8710 …

The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer

N Waingankar, R Jia, KE Marqueen, F Audenet… - … Oncology: Seminars and …, 2019 - Elsevier
Purpose Achieving a pathologic complete response (pCR) with neoadjuvant chemotherapy
(NAC) for muscle-invasive bladder cancer (MIBC) is associated with a favorable prognosis …

Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a …

L Boeri, M Soligo, I Frank, SA Boorjian… - World Journal of …, 2019 - Springer
Purpose To investigate the prevalence of and factors' association with receiving suboptimal
neoadjuvant chemotherapy (NAC) and its impact on survival outcomes in patients with …

Outcomes following clinical complete response to neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder in patients refusing radical …

D Robins, J Matulay, M Lipsky, A Meyer, R Ghandour… - Urology, 2018 - Elsevier
Objective To investigate survival outcomes of patients with muscle-invasive bladder cancer
(MIBC) that demonstrate complete clinical response (cT0) to neoadjuvant chemotherapy …

Refining the characterization and outcome of pathological complete responders after neoadjuvant chemotherapy for muscle-invasive bladder cancer: lessons from the …

S Culine, V Harter, C Krucker, G Gravis, A Fléchon… - Cancers, 2023 - mdpi.com
Simple Summary On the basis of a deep analysis of data collected in a randomized trial of
perioperative chemotherapy in muscle-invasive bladder cancer, we refined the …

A retrospective analysis of the effect on survival of time from diagnosis to neoadjuvant chemotherapy to cystectomy for muscle invasive bladder cancer

JC Park, NM Gandhi, MA Carducci… - The Journal of …, 2016 - auajournals.org
Purpose: We determine the impact of the timing of radical cystectomy from the diagnosis of
muscle invasive bladder cancer on survival in patients also treated with neoadjuvant …

Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?

R Catarino, L Alves, D Pereira, G Costa… - … Urology and Nephrology, 2022 - Springer
Purpose The most frequent histology of bladder tumors is urothelial carcinoma. Most are
pure urothelial carcinomas (PUC) but up to one-third of the cases present variant …

Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer

SM Stevenson, MR Danzig, RA Ghandour… - … Oncology: Seminars and …, 2014 - Elsevier
Objectives To determine the costs of treatment and the duration of survival, adjusted for
quality of life, for patients with muscle-invasive bladder cancer treated with immediate …

Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancer

MR Chappidi, M Kates, A Brant, AS Baras, GJ Netto… - Urology, 2017 - Elsevier
Objective To propose and validate a new approach to stratify clinically staged, organ-
confined, muscle-invasive bladder cancer patients (cT2N0M0) who are pathologic non …